These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


736 related items for PubMed ID: 25178429

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease.
    Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Ritz B, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson-Hiller AL, Goldman JG, Stebbins GT, Bernard B, Espay AJ, Revilla FJ, Devoto J, Rosenthal LS, Dawson TM, Albert MS, Tsuang D, Huston H, Yearout D, Hu SC, Cholerton BA, Montine TJ, Edwards KL, Zabetian CP.
    Mov Disord; 2016 Jan; 31(1):95-102. PubMed ID: 26296077
    [Abstract] [Full Text] [Related]

  • 4. Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease.
    Mengel D, Dams J, Ziemek J, Becker J, Balzer-Geldsetzer M, Hilker R, Baudrexel S, Kalbe E, Schmidt N, Witt K, Liepelt-Scarfone I, Gräber S, Petrelli A, Neuser P, Schulte C, Linse K, Storch A, Wittchen HU, Riedel O, Mollenhauer B, Ebentheuer J, Trenkwalder C, Klockgether T, Spottke A, Wüllner U, Schulz JB, Reetz K, Heber IA, Ramirez A, Dodel R.
    Parkinsonism Relat Disord; 2016 Aug; 29():112-6. PubMed ID: 27321987
    [Abstract] [Full Text] [Related]

  • 5. An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele.
    Shahid M, Kim J, Leaver K, Hendershott T, Zhu D, Cholerton B, Henderson VW, Tian L, Poston KL.
    Neurobiol Dis; 2019 Jul; 127():278-286. PubMed ID: 30826425
    [Abstract] [Full Text] [Related]

  • 6. The effect of MAPT H1 and APOE ε4 on transition from mild cognitive impairment to dementia.
    Samaranch L, Cervantes S, Barabash A, Alonso A, Cabranes JA, Lamet I, Ancín I, Lorenzo E, Martínez-Lage P, Marcos A, Clarimón J, Alcolea D, Lleó A, Blesa R, Gómez-Isla T, Pastor P.
    J Alzheimers Dis; 2010 Jul; 22(4):1065-71. PubMed ID: 20930301
    [Abstract] [Full Text] [Related]

  • 7. Associations of Sex, Race, and Apolipoprotein E Alleles With Multiple Domains of Cognition Among Older Adults.
    Walters S, Contreras AG, Eissman JM, Mukherjee S, Lee ML, Choi SE, Scollard P, Trittschuh EH, Mez JB, Bush WS, Kunkle BW, Naj AC, Peterson A, Gifford KA, Cuccaro ML, Cruchaga C, Pericak-Vance MA, Farrer LA, Wang LS, Haines JL, Jefferson AL, Kukull WA, Keene CD, Saykin AJ, Thompson PM, Martin ER, Bennett DA, Barnes LL, Schneider JA, Crane PK, Hohman TJ, Dumitrescu L, Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s Disease Genetics Consortium, and Alzheimer’s Disease Sequencing Project.
    JAMA Neurol; 2023 Sep 01; 80(9):929-939. PubMed ID: 37459083
    [Abstract] [Full Text] [Related]

  • 8. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD, Fisk JD, Rockwood K.
    Dement Geriatr Cogn Disord; 2003 Sep 01; 15(1):1-5. PubMed ID: 12457072
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease.
    Wang G, Huang Y, Chen W, Chen S, Wang Y, Xiao Q, Liu J, Fung VS, Halliday G, Chen S.
    Parkinsonism Relat Disord; 2016 Mar 01; 24():89-94. PubMed ID: 26776090
    [Abstract] [Full Text] [Related]

  • 12. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D.
    Arch Neurol; 2007 Sep 01; 64(9):1306-11. PubMed ID: 17846270
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ, Lee KS, Lee Y, Baek JH, Choi SH, Na DL, Seo SW, Oh BH, Hong CH.
    J Clin Psychiatry; 2012 Dec 01; 73(12):1555-62. PubMed ID: 23146133
    [Abstract] [Full Text] [Related]

  • 15. Interaction with the MAPT H1H1 Genotype Increases Dementia Risk in APOE ε4 Carriers in a Population of Southern India.
    Jairani PS, Aswathy PM, Gopala S, Verghese J, Mathuranath PS.
    Dement Geriatr Cogn Disord; 2016 Dec 01; 42(5-6):255-264. PubMed ID: 27705964
    [Abstract] [Full Text] [Related]

  • 16. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.
    Batterham PJ, Bunce D, Cherbuin N, Christensen H.
    Am J Geriatr Psychiatry; 2013 Oct 01; 21(10):1010-9. PubMed ID: 23567378
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 37.